Clinical Trials Logo
  1. Home
  2. Hypernatremia
  3. NCT04265976
  4. Details
NCT04265976 Clinical Trial

ED Hypernatremia. Prognostic Factors and Epidemiology.

Hypernatremia Clinical Trial

— NATSAU  

Official title:
Emergency Departement (ED) Hypernatremia. Prognostic Factors and Epidemiology. About a Single-center Prospective Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04265976
Other study ID # P/2019/448
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 26, 2019
Est. completion date September 1, 2020

Study information
Verified date February 2020
Source Centre Hospitalier Universitaire de Besancon
Contact Romain ADAM, Resident
Phone +33646470168
Email radam@chu-besancon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluate the 1-month mortality of patients who proceed a blood sample while in the ED with an hypernatremia (>145 mmol/l). This prospective study will try to show several prognostic factors, and show the epidemiology of hypernatremia in this single center evaluation.

Recruitment information / eligibility
Status Recruiting
Enrollment 250
Est. completion date September 1, 2020
Est. primary completion date May 26, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Natremia > 145 mmol/l

Exclusion Criteria:

- Age < 18 years

- Refusal

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France CHU Besançon Besançon

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary one month survival Survival at 1 month after the blood sample at the ED 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT02926989 - Intravenous Fluids in Hospitalised Children Phase 4
Not yet recruiting NCT05085223 - Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients
Withdrawn NCT01326429 - Frequency and Origin of Dysnatremias in the Emergency Department N/A
Completed NCT01456533 - Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients N/A
Recruiting NCT03658850 - Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients Phase 2
Not yet recruiting NCT06061783 - Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water N/A
Completed NCT02912299 - Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients N/A
Completed NCT01219179 - Use of Sterile Water Feeds for Treatment of Hypernatremia in Extremely Low Birth Weight Infants N/A
Completed NCT03752450 - Prospective Data Analysis of the Development of Hypernatremia in Intensive Care Unit
Recruiting NCT04949139 - Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia Phase 4
Completed NCT00734214 - Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial Phase 3
Recruiting NCT02449382 - Continuous Venovenous Hemofiltration Versus Conventional Treatment for Acute Severe Hypernatremia N/A
Withdrawn NCT01617798 - Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis N/A
Recruiting NCT05818826 - Early Versus Conventional Cessation of Hydrocortisone in Septic Shock Phase 2
Recruiting NCT01299428 - Evaluation of the Cerebral Oxygenation With Near Infrared Spectrophotometry (NIRS) at the Hypernatremic Dehydration in Newborn N/A
Completed NCT03610074 - Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC) N/A